```json
{
"ranked_hypotheses": [
{
"title": "Lysosomal Accumulation-Induced V-ATPase Inhibition (Osmotic Trapping)",
"description": "Non-hydrolyzed disaccharides accumulate within lysosomes due to resistance to lysosomal hydrolases, creating osmotic gradients that disrupt lysosomal membrane integrity and inhibit V-ATPase proton pumps. This prevents mTORC1 recruitment to lysosomal surfaces, enabling TFEB nuclear translocation. However, melibiose is hydrolyzed by α-galactosidase (activity in motoneurons unconfirmed), and other non-hydrolyzable disaccharides (sucrose, raffinose, cellobiose) do not produce equivalent autophagy, indicating specificity beyond simple resistance to hydrolysis. The dose-response is also problematic: pharmacological V-ATPase inhibitors work at nanomolar concentrations while disaccharides require ~100 mM.",
"target_gene": "ATP6V0C, ATP6V1 subunits (V-ATPase complex)",
"dimension_scores": {
"evidence_strength": 0.55,
"novelty": 0.60,
"feasibility": 0.35,
"therapeutic_potential": 0.30,
"mechanistic_plausibility": 0.50,
"druggability": 0.40,
"safety_profile": 0.50,
"competitive_landscape": 0.50,
"data_availability": 0.55,
"reproducibility": 0.50
},
"composite_score": 0.47,
"evidence_for": [
{"claim": "Trehalose directly inhibits V-ATPase activity", "pmid": "24728189"},
{"claim": "TFEB nuclear translocation requires mTORC1 dissociation from lysosomes", "pmid": "21543718"},
{"claim": "Lysosomal swelling observed with trehalose treatment", "pmid": "28334960"},
{"claim": "Trehalose is resistant to mammalian hydrolases", "pmid": "30335591"}
],
"evidence_against": [
{"claim": "Sucrose (osmotic agent) does not induce equivalent autophagy, suggesting osmotic stress alone is insufficient", "pmid": "24728189"},
{"claim": "Melibiose is hydrolyzed by α-galactosidase—intracellular stability in motoneurons unproven", "pmid": ""},
{"claim": "Other non-hydrolyzable disaccharides fail to produce equivalent effects, indicating specificity beyond hydrolysis resistance", "pmid": ""},
{"claim": "Dose-response mismatch: bafilomycin works at nM concentrations vs mM for disaccharides", "pmid": ""}
]
},
{
"title": "cAMP/PKA-Dependent Transcription Factor Activation via Nutrient Stress Sensing",
"description": "Structurally diverse disaccharides trigger a general nutrient stress response via unidentified membrane sensors, elevating cAMP and activating PKA. PKA phosphorylates CREB and activates CRTC2, which drives TFEB transcriptional coactivation. Major weaknesses: cAMP elevation evidence is from yeast (PMID: 17607311), lactulose's SCFA mechanism requires gut bacteria (irrelevant to cultured neurons), and PKA canonically INHIBITS autophagy via ULK1 phosphorylation at Ser757 (PMID: 22948138), contradicting the hypothesis unless non-canonical CRTC2 coactivation operates. The 6-24 hour TFEB translocation timeline also mismatches the transient (seconds-to-minutes) kinetics typical of PKA activation. No membrane receptor has been identified.",
"target_gene": "PRKACA, CREB1, CRTC2",
"dimension_scores": {
"evidence_strength": 0.35,
"novelty": 0.65,
"feasibility": 0.55,
"therapeutic_potential": 0.50,
"mechanistic_plausibility": 0.40,
"druggability": 0.60,
"safety_profile": 0.35,
"competitive_landscape": 0.50,
"data_availability": 0.30,
"reproducibility": 0.35
},
"composite_score": 0.42,
"evidence_for": [
{"claim": "cAMP-elevating agents can induce autophagy in certain contexts", "pmid": "20085788"},
{"claim": "CRTC2 promotes TFEB transcriptional activity", "pmid": "27999501"},
{"claim": "Trehalose increases intracellular cAMP in yeast", "pmid": "17607311"}
],
"evidence_against": [
{"claim": "PKA phosphorylates ULK1 at Ser757, promoting mTORC1-mediated inhibition of autophagy initiation—canonical pathway contradicts the hypothesis", "pmid": "22948138"},
{"claim": "CRTC2 knockdown does not fully prevent nutrient-deprivation-induced autophagy; it is permissive, not master regulatory", "pmid": ""},
{"claim": "Lactulose fermentation to SCFAs requires gut bacteria, irrelevant to cultured motoneurons", "pmid": "25109855"},
{"claim": "cAMP/PKA activation is transient (seconds-minutes); TFEB translocation occurs at 6-24 hours—temporal mismatch", "pmid": ""},
{"claim": "No identified membrane sensor for disaccharide detection", "pmid": ""}
]
},
{
"title": "Parallel Multi-Pathway Convergence on TFEB Activation",
"description": "Structurally diverse disaccharides activate autophagy through independent, parallel mechanisms that converge on TFEB: trehalose via V-ATPase/mTORC1 inhibition, melibiose via partial α-galactosidase substrate action generating signaling metabolites, and lactulose via non-cell-autonomous effects (if systemic) or alternative stress pathways. This explains why individual knockdown of any single pathway does not fully block disaccharide effects, while global outcomes remain similar. Requires comprehensive pathway mapping and temporal dissection.",
"target_gene": "Multiple convergence points; TFEB as master regulator",
"dimension_scores": {
"evidence_strength": 0.40,
"novelty": 0.70,
"feasibility": 0.45,
"therapeutic_potential": 0.45,
"mechanistic_plausibility": 0.55,
"druggability": 0.35,
"safety_profile": 0.45,
"competitive_landscape": 0.60,
"data_availability": 0.30,
"reproducibility": 0.40
},
"composite_score": 0.45,
"evidence_for": [
{"claim": "Structural diversity of active compounds makes single-target mechanism unlikely", "pmid": ""},
{"claim": "Lactulose has distinct metabolic fate from trehalose/melibiose", "pmid": ""},
{"claim": "TFEB can be activated via multiple pathways (mTORC1, calcineurin)", "pmid": "28528822"}
],
"evidence_against": [
{"claim": "More complex mechanism with no single druggable target emerging", "pmid": ""},
{"claim": "Difficult to design drugs that mimic multi-pathway convergence", "pmid": ""},
{"claim": "Requires extensive pathway mapping before therapeutic application", "pmid": ""}
]
}
],
"knowledge_edges": [
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "ATP6V0C", "target_type": "gene", "relation": "directly_inhibits"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "ATP6V1A", "target_type": "gene", "relation": "directly_inhibits"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "MTOR", "target_type": "gene", "relation": "disinhibits_via_lysosomal_dissociation"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "TFEB", "target_type": "gene", "relation": "enables_nuclear_translocation"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "Rraga", "target_type": "gene", "relation": "modulates_lysosomal_recruitment"},
{"source_id": "Hypothesis 2 (cAMP/PKA)", "source_type": "hypothesis", "target_id": "PRKACA", "target_type": "gene", "relation": "directly_activates"},
{"source_id": "Hypothesis 2 (cAMP/PKA)", "source_type": "hypothesis", "target_id": "CREB1", "target_type": "gene", "relation": "directly_phosphorylates"},
{"source_id": "Hypothesis 2 (cAMP/PKA)", "source_type": "hypothesis", "target_id": "CRTC2", "target_type": "gene", "relation": "directly_activates"},
{"source_id": "Hypothesis 2 (cAMP/PKA)", "source_type": "hypothesis", "target_id": "TFEB", "target_type": "gene", "relation": "coactivates_transcription"},
{"source_id": "Hypothesis 2 (cAMP/PKA)", "source_type": "hypothesis", "target_id": "ULK1", "target_type": "gene", "relation": "phosphorylates_inhibitory_ser757"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "Trehalose", "target_type": "compound", "relation": "accumulates_in_lysosome"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "Melibiose", "target_type": "compound", "relation": "requires_α-galactosidase_activity_status"},
{"source_id": "Hypothesis 1 (V-ATPase)", "source_type": "hypothesis", "target_id": "Lactulose", "target_type": "compound", "relation": "alternative_metabolism_unclear"},
{"source_id": "Skeptic_Falsification", "source_type": "evidence", "target_id": "Raffinose", "target_type": "compound", "relation": "negative_control"},
{"source_id": "Skeptic_Falsification", "source_type": "evidence", "target_id": "Cellobiose", "target_type": "compound", "relation": "negative_control"},
{"source_id": "Skeptic_Falsification", "source_type": "evidence", "target_id": "Sucrose", "target_type": "compound", "relation": "negative_control"}
],
"synthesis_summary": "The convergent autophagy induction by trehalose, melibiose, and lactulose presents a mechanistic puzzle not explained by either the V-ATPase inhibition or cAMP/PKA hypotheses alone. The V-ATPase hypothesis (composite score 0.47) has stronger direct evidence for trehalose (PMID: 24728189, 21543718) but fails to explain why other non-hydrolyzable disaccharides lack equivalent activity and is undermined by a 10^6-fold concentration disparity between pharmacological and disaccharide-mediated V-ATPase effects. The cAMP/PKA hypothesis (composite score 0.42) is weakened by heavy reliance on yeast data, the mechanistic contradiction that PKA canonically inhibits autophagy via ULK1 Ser757 phosphorylation, and the irrelevance of lactulose fermentation to cultured neurons. The clinical development path for both hypotheses is severely constrained by the ~100 mM requirement, poor CNS penetration of glycosylated molecules, and unacceptable systemic toxicity from V-ATPase inhibition. The most tractable path forward requires: (1) [$^{13}$C]-disaccharide tracing to definitively establish intracellular accumulation in relevant cell types, (2) raffinose/cellobiose challenge experiments to test selectivity beyond hydrolysis resistance, and (3) unbiased kinome/proteome profiling to identify unanticipated targets. Neither hypothesis currently supports rational drug design; the disaccharides themselves may be the only viable therapeutic entities, which would require overcoming fundamental pharmacokinetic barriers through novel formulation or prodrug strategies."
}
```